Flow Cytometry Blood Test for Myeloma MRD Detection Launches
The test offers sensitivity comparable to next-generation sequencing methods while using noninvasive blood specimens instead of bone marrow aspirates.
Read MorePosted by CLP Edit Staff | Feb 2, 2026 | Flow Cytometry |
The test offers sensitivity comparable to next-generation sequencing methods while using noninvasive blood specimens instead of bone marrow aspirates.
Read MorePosted by CLP Edit Staff | Feb 2, 2026 | Mass Spectrometry |
Labcorp will deploy Roche’s cobas Mass Spec platform in its US labs, marking the first commercial rollout of this fully automated mass spectrometry system to streamline complex diagnostic testing workflows.
Read MorePosted by CLP Edit Staff | Jan 28, 2026 | Company News |
Labcorp will build a 500,000-square-foot facility in Brownsburg, Indiana, expanding its Indianapolis-area lab capacity by 40% to support clinical trial operations.
Read MorePosted by CLP Edit Staff | Jan 27, 2026 | Covid 19, Flu & Respiratory Infections |
University Hospital Southampton is trialing a point-of-care biosensor test for flu, COVID-19, and RSV, delivering results in four minutes, according to the hospital.
Read MorePosted by CLP Edit Staff | Jan 27, 2026 | Cancer |
A real-world study of 111,080 participants found the Galleri multi-cancer blood test achieved a 0.91% cancer detection rate and 87% accuracy in predicting tumor origin.
Read More